METTL14 Regulates the m6A Modification of TRAF6 to Suppress Mitochondrial Dysfunction and Ferroptosis in Dopaminergic Neurons via the cGAS-STING Pathway

被引:6
|
作者
Shao, Liang [1 ]
Hu, Fan [2 ]
Xu, Renxu [2 ]
Nie, Hongbing [2 ]
Zhang, Hong [2 ]
Zhang, Ping [2 ]
机构
[1] Nanchang Med Coll, Jiangxi Prov Peoples Hosp, Affiliated Hosp 1, Dept Cardiol, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Med Coll, Jiangxi Prov Peoples Hosp, Affiliated Hosp 1, Dept Neurol, Nanchang 330006, Jiangxi, Peoples R China
关键词
METTL14; TRAF6; cGAS-STING pathway; parkinson's disease; ferroptosis; mitochondrial dysfunction; dopaminergic neurons; PARKINSONS-DISEASE; UBIQUITINATION; ALPHA;
D O I
10.2174/0115665240263859231018110107
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives The degeneration of dopaminergic (DA) neurons has emerged as a crucial pathological characteristic in Parkinson's disease (PD). To enrich the related knowledge, we aimed to explore the impact of the METTL14-TRAF6-cGAS-STING axis in mitochondrial dysfunction and ferroptosis underlying DA neuron degeneration. Methods 1-methyl-4-phenylpyridinium ion (MPP+) was used to treat DA neuron MN9D to develop the PD cell models. Afterward, a cell counting kit, flow cytometer, DCFH-DA fluorescent probe, and Dipyrromethene Boron Difluoride staining were utilized to measure the cell viability, iron concentration, ROS level, and lipid peroxidation, respectively. Meanwhile, the mitochondrial ultrastructure, the activity of mitochondrial respiratory chain complexes, and levels of malondialdehyde and glutathione were monitored. In addition, reverse transcription-quantitative polymerase chain reaction and western blot assays were adopted to measure the expression of related genes. cGAS ubiquitylation and TRAF6 messenger RNA (mRNA) N6-methyladenosine (m6A) levels, the linkages among METTL14, TRAF6, and the cGAS-STING pathway were also evaluated. Results METTL14 expression was low, and TRAF6 expression was high after MPP+ treatment. In MPP+-treated MN9D cells, METTL14 overexpression reduced ferroptosis, ROS generation, mitochondrial injury, and oxidative stress (OS) and enhanced mitochondrial membrane potentials. TRAF6 overexpression had promoting impacts on mitochondrial dysfunction and ferroptosis in MPP+-treated MN9D cells, which was reversed by further overexpression of METTL14. Mechanistically, METTL14 facilitated the m6A methylation of TRAF6 mRNA to down-regulate TRAF6 expression, thus inactivating the cGAS-STING pathway. Conclusion METTL14 down-regulated TRAF6 expression through TRAF6 m6A methylation to inactivate the cGAS-STING pathway, thereby relieving mitochondrial dysfunction and ferroptosis in DA neurons.
引用
收藏
页码:1518 / 1528
页数:11
相关论文
共 50 条
  • [21] METTL14 facilitates the process of sexual reversal via m6A RNA methylation in Pelodiscus sinensis
    Zhou, Tong
    Chen, Guobin
    Cao, Jizeng
    Ji, Huizi
    Zou, Guiwei
    Liang, Hongwei
    GENOMICS, 2025, 117 (03)
  • [22] METTL14 promotes IL-6-induced viability, glycolysis and inflammation in HaCaT cells via the m6A modification of TRIM27
    Chen, Yiran
    Xiang, Yanwei
    Miao, Xiao
    Kuai, Le
    Ding, Xiaojie
    Ma, Tian
    Li, Bin
    Fan, Bin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (03)
  • [23] METTL14 promotes the development of diabetic kidney disease by regulating m6A modification of TUG1
    Zheng, Yingying
    Zhang, Zhengjun
    Zheng, Dejie
    Yi, Pengfei
    Wang, Shaoqiang
    ACTA DIABETOLOGICA, 2023, 60 (11) : 1567 - 1580
  • [24] METTL14 promotes the development of diabetic kidney disease by regulating m6A modification of TUG1
    Yingying Zheng
    Zhengjun Zhang
    Dejie Zheng
    Pengfei Yi
    Shaoqiang Wang
    Acta Diabetologica, 2023, 60 : 1567 - 1580
  • [25] A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth
    Miyake, Kotaro
    Cruz, Pedro Henrique Costa
    Nagatomo, Izumi
    Kate, Yuki
    Motooka, Daisuke
    Satoh, Shingo
    Adachi, Yuichi
    Takeda, Yoshito
    Kawahara, Yukio
    Kumanogoh, Atsushi
    CELL REPORTS, 2023, 42 (07):
  • [26] The M6A Methyltransferase METTL14 Promotes Myelodysplastic Syndromes Development Via PI3K/Akt Signaling Pathway
    Jiang, Lingxu
    Zhou, Xinping
    Hu, Chao
    Mei, Chen
    Xu, Gaixiang
    Ma, Liya
    Ren, Yanling
    Ye, Li
    Wang, Lu
    Luo, Yingwan
    Jin, Jie
    Sun, Jie
    Tong, Hongyan
    BLOOD, 2022, 140 : 6894 - 6895
  • [27] METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer
    Li, Lijie
    Zeng, Jie
    He, Sili
    Yang, Yanfei
    Wang, Chen
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [28] METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho (vol 27, 106, 2021)
    Li, Manna
    Deng, Le
    Xu, Gaosi
    MOLECULAR MEDICINE, 2022, 28 (01)
  • [29] The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-κB pathway
    Wen, Linbao
    Sun, Wei
    Xia, Dayong
    Wang, Yanming
    Li, Junpeng
    Yang, Song
    NEUROREPORT, 2022, 33 (06) : 243 - 251
  • [30] m6A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-?B pathway and ROS production
    Qi, Lei
    Wang, Ye
    Hu, Hui
    Li, Pingjiang
    Hu, Hesheng
    Li, Yan
    Wang, Kang
    Zhao, Yuepeng
    Feng, Meng
    Lyu, Hangji
    Yin, Jie
    Shi, Yugen
    Wang, Yu
    Li, Xiaolu
    Yan, Suhua
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 170 : 87 - 99